Cerovive - Neuroprotectant for the Treatment of Acute Ischaemic Stroke

 

Key Data:

Drug (brand/generic)
Cerovive
Company/licensee
Renovis/AstraZeneca
Therapy class
Neuroprotectant
Product description
Nitrone-based free radical scavenger
Current indication
Treatment of acute ischaemic stroke
Market sector
CNS
Development status
Discontinued



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development